Target intelligence / Profile preview

Crotalinae venom

Molecular classification
Enzyme, Other (Toxins and non-enzymatic proteins)
01

Overview

Crotalinae venom is a complex mixture of bioactive proteins and peptides produced by pit vipers, a subfamily of venomous snakes that includes rattlesnakes, copperheads, and cottonmouths (StatPearls, 2023). The venom serves both to immobilize prey and initiate digestion, containing a diverse array of toxins such as snake venom metalloproteinases (SVMPs), phospholipases A2 (PLA2s), and serine proteases (Journal of Venomous Animals and Toxins, 2016). These components act synergistically to cause local tissue destruction, systemic coagulopathy, and cardiovascular instability in human victims (NIH, 2021). In a therapeutic context, Crotalinae venom is the primary target for antivenom treatments, which utilize purified antibody fragments to bind and neutralize the toxic components (FDA, 2018). These antivenoms, such as CroFab and Anavip, are essential for managing complications like coagulopathy and preventing permanent tissue damage (Unified Treatment Algorithm, 2011). Understanding the specific composition of Crotalinae venom is crucial for the development of effective treatments for snakebite envenomation and managing its clinical sequelae (WHO, 2017).

Other names
Pit viper venomCrotalid venomRattlesnake venomCopperhead venomCottonmouth venom
02

Mechanism of action

The mechanism of action involves the administration of venom-specific antibody fragments (Fab or F(ab')2) that bind to and neutralize the toxic proteins within the venom, preventing their interaction with host tissues and facilitating their clearance (FDA, 2018; StatPearls, 2023).

03

Biological functions

Cell deathOther (Proteolysis and Hemostasis disruption)
04

Disease associations

InflammationCardiovascular diseaseOther (Snakebite envenomation)
05

Safety considerations

Anaphylaxis (StatPearls, 2023)Serum sicknessAcute hypersensitivity reactionsRecurrent venom effects (coagulopathy)
06

Interacting drugs

Crotalidae Polyvalent Immune Fab (CroFab)

2 more in the full profile.

07

Biomarkers

Fibrinogen level (Unified Treatment Algorithm, 2011)Platelet countProthrombin time (PT)Creatine kinase (CK)

Beyond the preview

Go deeper on Crotalinae venom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crotalinae venom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call